CMV reactivation post-allogeneic HSCT in a patient with GvHD, neutropenia, and renal failure

This video podcast has been developed with the assistance of Dr. Lana Desnica (University Hospital Center Zagreb, Croatia).

This program was supported by a non-CME educational grant from Biotest. This activity is intended for healthcare professionals practicing globally.

To proceed, please confirm that you are a healthcare professional.

Dr. Desnica has made the following financial disclosures:
Speaker’s fees: Biotest, Takeda. The information presented is not intended as medical advice, and is being made available for educational purposes only.

This material is not intended to represent the best or only methods or procedures appropriate for the medical situation discussed; rather, the material is intended to present an approach, view, statement or opinion of the authors or presenters, which may be helpful, or of interest to other healthcare professionals. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location.

Previous
Previous

A 22-year-old kidney transplant recipient presenting with new MAHA

Next
Next

A 62-year-old woman with R/R DLBCL after 2 lines of systemic therapy